Serum Adiponectin Relates to Shortened Overall Survival in Men with Squamous Cell Esophageal Cancer Treated with Preoperative Concurrent Chemoradiotherapy: A Pilot Study
Open Access
- 1 January 2014
- journal article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 20, 2351-2357
Abstract
The convergence of nutritional, genetic, and inflammatory factors plays a significant role in the pathophysiology of squamous cell esophageal cancer (SCEC). The parameters of inflammation, indices of nutritional status, and adipocyte-derived hormones such as leptin, adiponectin, and resistin have been shown to be prognostic factors in some gastrointestinal and pancreatic cancers. Forty-two patients with SCEC were subjected to a multimodal regimen of concurrent neoadjuvant chemoradiotherapy (CRT) followed by surgery. We retrospectively analyzed the impact of pretreatment values of serum leptin, adiponectin, resistin, soluble leptin receptor, C-reactive protein, TNF alpha, leukocytes, and indices of nutritional status (BMI, plasma total protein, albumin, cholesterol, and triacylglycerols) on overall survival (OS). Univariate analysis revealed significant a negative correlation between OS and serum adiponectin (p=0.027), and a positive relationship was found between serum albumin (p=0.002), cholesterol (p=0.049) level, and OS. In multivariate analysis, only the trend (p=0.086) for negative serum adiponectin association with the OS was observed. In men with SCEC treated by neoadjuvant concurrent CRT and esophagectomy, high pretreatment level of serum adiponectin was associated with shorter OS while the serum albumin and cholesterol were associated with longer OS.Keywords
This publication has 52 references indexed in Scilit:
- The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNSFEBS Letters, 2007
- Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progressionEndocrine-Related Cancer, 2007
- Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisThe Lancet Oncology, 2007
- Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patientsCancer, 2006
- White Blood Cell Count and the Risk of Colon CancerYonsei Medical Journal, 2006
- Leptin and cancerJournal of Cellular Physiology, 2005
- Plasma Adiponectin and Gastric CancerClinical Cancer Research, 2005
- WBC Count and the Risk of Cancer Mortality in a National Sample of U.S. Adults: Results from the Second National Health and Nutrition Examination Survey Mortality StudyCancer Epidemiology, Biomarkers & Prevention, 2004
- Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese SubjectsThe Journal of Clinical Endocrinology & Metabolism, 2003
- Adiponectin and resistin--new hormones of white adipose tissue.2003